WhiteBoard Style discussion on a randomized trial that came out comparing those with mild to moderate COVID-19 who were treated with either ivermectin and doxycycline versus hydroxychloroquine and azithromycin. They found similar duration to viral clearance and similar duration to symptom recovery with an interesting trend towards favoring the ivermectin and doxycycline group. There were no placebo or “usual care” groups to compare to. One of the few studies looking at treatment for COVID-19 at earlier stages in the disease process!
Link to article:
There will be a running series of videos using the most up to date information on COVID-19, but this is an evolving field and new videos may come out that contradict that previous information. That is okay and is the nature of a fast paced and evolving clinical scenario. Stick with us as we work to unveil the intricacies of COVID-19, it’s clinical significance, and the societal implications. *****This is strictly educational and not to be mistaken as clinical recommendations, please verify all information with accepted guidelines and practice patterns.****
